The healthcare landscape for glucose is changing, and transdermal GLP-1 delivery systems represent a exciting development. Unlike injections, this method offers a simpler way to provide GLP-1 drugs. These transdermal systems gradually release the treatment through the skin offering a consistent amount of the beneficial agent, which can improve gluc